首页> 美国卫生研究院文献>Cardiovascular Diabetology >Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind randomized three-arm unicenter study
【2h】

Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind randomized three-arm unicenter study

机译:胰岛素和甘精胰岛素对2型糖尿病患者生长和循环内皮祖细胞数量的影响:部分双盲随机三臂单中心研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEndothelial progenitor cells (EPC) are bone marrow-derived cells which can undergo differentiation into endothelial cells and participate in endothelial repair and angiogenesis. Insulin facilitates this in vitro mediated by the IGF-1 receptor. Clinical trials showed that the number of circulating EPCs is influenced by glucose control and EPC are a predictor of cardiovascular death. To study direct effects of insulin treatment on EPCs in type 2 diabetes patients, add-on basal insulin treatment was compared to an escalation of oral medication aiming at similar glucose control between the groups.
机译:背景内皮祖细胞(EPC)是骨髓来源的细胞,可以经历分化为内皮细胞并参与内皮修复和血管生成。胰岛素在体外促进了IGF-1受体介导的作用。临床试验表明,循环中的EPC的数量受血糖控制的影响,而EPC是心血管死亡的预测指标。为了研究胰岛素治疗对2型糖尿病患者EPC的直接影响,将附加基础胰岛素治疗与口服药物逐步升级进行了比较,目的是在两组之间进行类似的血糖控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号